Literature DB >> 6338807

Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation?

R C Griggs, M J Rennie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6338807     DOI： 10.1002/ana.410130204

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  10 in total

1.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

2.  Altered ribosomal protein synthesis in congenital non-progressive myopathy.

Authors:  H Pöche; E Kattner
Journal:  Klin Wochenschr       Date:  1987-12-01

3.  Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: Use in studies of human tissue protein synthesis.

Authors:  P W Watt; Y Lindsay; C M Scrimgeour; P A Chien; J N Gibson; D J Taylor; M J Rennie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Authors:  Chad R Heatwole; Katy J Eichinger; Deborah I Friedman; James E Hilbert; Carlayne E Jackson; Eric L Logigian; William B Martens; Michael P McDermott; Shree K Pandya; Christine Quinn; Alexis M Smirnow; Charles A Thornton; Richard T Moxley
Journal:  Arch Neurol       Date:  2010-09-13

5.  Glutamine supplementation in sick children: is it beneficial?

Authors:  Elise Mok; Régis Hankard
Journal:  J Nutr Metab       Date:  2011-11-14

Review 6.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

7.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

8.  The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.

Authors:  Hannah G Radley-Crabb; Marta L Fiorotto; Miranda D Grounds
Journal:  PLoS Curr       Date:  2011-11-15

9.  A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Davy van de Vijver; Joke W Boertje-van der Meulen; Kayleigh Putker; Kevin Adamzek; Annemieke Aartsma-Rus; Maaike van Putten
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

10.  Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1.

Authors:  Marie-Pier Roussel; Marika Morin; Mélina Girardin; Anne-Marie Fortin; Mario Leone; Jean Mathieu; Cynthia Gagnon; Elise Duchesne
Journal:  BMC Res Notes       Date:  2019-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.